MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.510
+0.010 (0.22%)
Mar 9, 2026, 4:00 PM EDT - Market closed
MiMedx Group Revenue
In the year 2025, MiMedx Group had annual revenue of $418.63M with 19.99% growth. MiMedx Group had revenue of $118.10M in the quarter ending December 31, 2025, with 27.11% growth.
Revenue (ttm)
$418.63M
Revenue Growth
+19.99%
P/S Ratio
1.62
Revenue / Employee
$518,106
Employees
808
Market Cap
670.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 418.63M | 69.75M | 19.99% |
| Dec 31, 2024 | 348.88M | 27.40M | 8.52% |
| Dec 31, 2023 | 321.48M | 53.64M | 20.03% |
| Dec 31, 2022 | 267.84M | 25.82M | 10.67% |
| Dec 31, 2021 | 242.02M | -6.22M | -2.50% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMDXG News
- 4 days ago - MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields - GlobeNewsWire
- 12 days ago - MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - GlobeNewsWire
- 20 days ago - MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 - GlobeNewsWire
- 4 weeks ago - MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products - GlobeNewsWire
- 5 weeks ago - MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX® - GlobeNewsWire
- 2 months ago - MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - GlobeNewsWire
- 4 months ago - MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial - GlobeNewsWire